ABSTRACT
Background Assessing fidelity in complex interventions is important. Ignoring it increases the risk of discarding potentially effective interventions that failed to work because they were not implemented as intended or, accepting ineffective interventions whose effects were brought about by factors other than the intervention. Unlike simple interventions, fidelity assessment in complex interventions is underexplored and not straightforward. Adapting the evaluative approach used in Objective Structured Clinical Exams (OSCEs), we describe the development and validation of an easy to use, objective approach to fidelity assessment – the Overall Fidelity Enactment Scale for use in complex interventions (the OFES-CI).
Methods We developed the OFES-CI and assessed its accuracy using secondary data collected as part of the process evaluation of the SCOPE intervention. Specifically, we compared the OFES-CI ratings obtained from trained study observers during SCOPE intervention workshops to more detailed and comprehensive qualitative fidelity enactment data collected between and during the same workshops (our gold standard).
Results The OFES-CI demonstrates acceptable reliability against our gold standard assessment approach and addresses the practicality problem in fidelity assessment by virtue of its suitable implementation qualities (acceptability, ease of completion, low burden, low training requirements). It can be easily adapted to assess enactment of a variety of complex interventions.
Conclusions Global ratings approaches validated in the context of assessing clinician competence in OSCEs provide a novel, practical and underexplored opportunity to assess fidelity enactment in complex trials. Given important questions that are increasingly being asked regarding evaluation of complex pragmatic interventions, the proposed approach to fidelity assessment, if incorporated into trial evaluation, stands to provide valuable insights not only into why an intervention may succeed or fail but also how we might carry out adaptations of complex interventions when they are needed.
KEY ARTICLE MESSAGES
There is a growing knowledge base regarding how to assess the fidelity with which complex interventions (trials) are delivered, though there is relatively little knowledge regarding how to efficiently assess the fidelity with which they are implemented (enacted) by intervention participants. Data on fidelity enactment is critical for proper interpretation of trial outcomes.
The present study provides an easy-to-use, valid and reliable approach to assessment of fidelity enactment for use in complex trials (the OFES-CI) and outlines specific procedures for assessing fidelity.
The OFES-CI can be easily adapted for practical assessment of fidelity of other complex interventions. Such fidelity data can help address well known problems with trial replication by providing valuable insight into why interventions succeed or fail and what adaptations may be needed to promote greater success.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a Canadian Institutes of Health Research (CIHR) Transitional Operating Grant CIHR PS 148582 Wagg
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Research Ethics Boards of the University of Alberta (Pro00000012517), University of British Columbia (H14-03286), Operational approval was obtained from all included facilities as required. SCOPE sponsors and team members were asked for informed consent prior to taking part in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors provided they adhere to our data confidentiality and access policies.
